delamanid expanded access novel treatment of drug resistant tuberculosis [corrigendum]

delamanid expanded access novel treatment of drug resistant tuberculosis [corrigendum]

;Rustomjee R;Zumla A
clinical gastroenterology and hepatology : the official clinical practice journal of the american gastroenterological association 2016 Vol. 2016 pp. 43-45
70
r2016infectiondelamanid

Abstract

Rustomjee R, Zumla A. Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 2015;8:359–366. Dr Rustomjee and Professor Zumla are grateful to a reader for raising some issues regarding referencing, and interpretation of their paper, and would like to clarify and address these issues. Read the original article 

Citation

ID: 128589
Ref Key: r2016infectiondelamanid
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
128589
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet